Illumina Inc (ILMN.O)

ILMN.O on Nasdaq

72.05USD
11:04am EDT
Price Change (% chg)

$-0.53 (-0.73%)
Prev Close
$72.58
Open
$72.38
Day's High
$72.68
Day's Low
$71.76
Volume
657,994
Avg. Vol
1,355,933
52-wk High
$77.11
52-wk Low
$37.77

ILMN.O

Chart for ILMN.O

About

Illumina, Inc. (Illumina) is a developer and manufacturer of life science tools and integrated systems for the analysis of genetic variation and function. The Company provides a line of genetic analysis solutions, with products and services that serve a range of interconnected markets, including sequencing, genotyping, gene... (more)

Overall

Beta: 0.66
Market Cap (Mil.): $9,027.39
Shares Outstanding (Mil.): 124.38
Dividend: --
Yield (%): --

Financials

  ILMN.O Industry Sector
P/E (TTM): 97.04 76.80 35.13
EPS (TTM): 0.75 -- --
ROI: 4.72 4.25 18.83
ROE: 8.29 9.07 19.68
Search Stocks

BRIEF-Illumina shares up 4.3 pct after the bell

NEW YORK, April 22 - Illumina Inc : * Shares up 4.3 percent after the bell following results

22 Apr 2013

CORRECTED-BRIEF-Illumina ordered to pay about $96 mln in patent damages

March 14 - March 14 - Illumina Inc :

14 Mar 2013

BRIEF-Illumina shares down in premarket

NEW YORK, Jan 7 - Illumina Inc : * Down 7.3 percent to $50.75 in premarket

07 Jan 2013

Swiss stocks - Factors to watch on Jan 7

ZURICH, Jan 7 - The following are some of the main factors expected to affect Swiss stocks on Monday.

07 Jan 2013

Illumina to buy Verinata Health for $350 mln plus milestone payments

Jan 7 - U.S. genetic sequencing company Illumina Inc said it has agreed to buy Verinata Health Inc for $350 million plus up to $100 million in milestone payments through 2015 to expand its footprint in prenatal testing options.

07 Jan 2013

Roche chairman says Illumina bid off the table: paper

ZURICH - Swiss pharmaceutical group Roche is no longer considering a bid for U.S. gene-sequencing company Illumina , Chairman Franz Humer was quoted as saying in a newspaper interview on Sunday.

06 Jan 2013

Illumina shares jump on report of new Roche bid

ZURICH - Shares in Illumina jumped 7 percent on Thursday, after Swiss newspaper L'Agefi reported that Roche may have reached an agreement to buy the U.S. gene-sequencing company.

21 Dec 2012

Illumina shares jump on report of new Roche bid

ZURICH - Shares in Illumina jumped 7 percent on Thursday, after Swiss newspaper L'Agefi reported that Roche may have reached an agreement to buy the U.S. gene-sequencing company.

20 Dec 2012

Illumina shares jump on report of new Roche bid

ZURICH, Dec 20 - Shares in Illumina jumped 7 percent on Thursday, after Swiss newspaper L'Agefi reported that Roche may have reached an agreement to buy the U.S. gene-sequencing company.

20 Dec 2012

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Market Edge
$10.00
Provider: GlobalData
$250.00
Provider: S&P Capital IQ – STARS Reports
$115.00
Provider: Pechala's Reports
$15.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks